CDK4 and cancer: SRGs were enriched in the cell cycle pathway related to 5‐FU resistance.[18] The inhibition of cyclin‐dependent kinase 4/6 (CDK4/6) displayed a synergistic effect with 5‐FU in GC.[19] In terms of cellular metabolism, SRGs were enriched in central carbon metabolism in cancer (CCM).